Kingswood Wealth Advisors LLC Invests $525,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Kingswood Wealth Advisors LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 883 shares of the biotechnology company's stock, valued at approximately $525,000.

Other institutional investors have also modified their holdings of the company. Public Sector Pension Investment Board grew its holdings in shares of Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc lifted its stake in Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock valued at $4,227,000 after buying an additional 895 shares during the last quarter. Foundations Investment Advisors LLC acquired a new position in shares of Axon Enterprise during the third quarter valued at $221,000. Sequoia Financial Advisors LLC grew its position in shares of Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company's stock worth $690,000 after acquiring an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC bought a new position in shares of Axon Enterprise during the third quarter worth about $814,000. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Up 1.7 %

Shares of AXON stock traded up $10.99 on Thursday, hitting $650.96. The company's stock had a trading volume of 242,265 shares, compared to its average volume of 549,240. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market capitalization of $49.64 billion, a price-to-earnings ratio of 168.21, a P/E/G ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a fifty-two week low of $247.04 and a fifty-two week high of $698.67. The firm's fifty day moving average price is $618.90 and its 200-day moving average price is $477.78.

Analysts Set New Price Targets

Several equities research analysts have commented on AXON shares. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research note on Monday. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Finally, TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus price target of $524.85.

Insider Transactions at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now owns 24,259 shares of the company's stock, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.